Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 3

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 3
---
 subsidiary.

TABLE OF CONTENTS

MEETING AGENDA

| Proposals                                                                                                                                                                                 |     | Page |     | Voting Required for Approval                                                                                                                                               |     | Board Recommendation                                                                          |
| Proposal No. 1: To elect the five nominees for director named in this Proxy Statement for a one-year term expiring at the 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) |     |    7 |     | The five nominees for director receiving a plurality of the votes cast “FOR” election will be elected as directors for a one-year term expiring at the 2026 Annual Meeting |     | “FOR ALL” for the election of the named director nominees                                     |
| Proposal No. 2: To approve, on an advisory basis, the compensation of our named executive officers                                                                                        |     |    8 |     | Affirmative vote of the majority of votes cast on this Proposal                                                                                                            |     | “FOR” the approval, on an advisory basis, of the compensation of our named executive officers |
| Proposal No. 3: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026                                      |     |    9 |     | Affirmative vote of the majority of votes cast on this Proposal                                                                                                            |     | “FOR” the ratification of the appointment of KPMG LLP                                         |

TABLE OF CONTENTS

TABLE OF CONTENTS

| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING                                |     |  1 |
| PROPOSAL NO. 1 ELECTION OF FIVE DIRECTORS                                                   |     |  7 |
| PROPOSAL NO. 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION                                      |     |  8 |
| PROPOSAL NO. 3 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |     |  9 |
| INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE                       |     | 10 |
| EXECUTIVE OFFICERS                                                                          |     | 19 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                              |     | 21 |
| EXECUTIVE COMPENSATION                                                                      |     | 23 |
| DIRECTOR COMPENSATION                                                                       |     | 29 |
| SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION